<DOC>
	<DOCNO>NCT00245934</DOCNO>
	<brief_summary>The purpose study investigate incidence adverse event patient rheumatoid arthritis treat Enbrel usual care setting . In addition , difference injection site reaction base whether health care professional patient administer Enbrel assess evaluate .</brief_summary>
	<brief_title>Study Evaluating Enbrel Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Proven diagnosis rheumatoid arthritis Contraindications accord Summary Product Characteristic ( SmPC ) Enbrel® follow point prevent restrict participation : Patients suffer hypersensitivity active substance Etanercept excipients Enbrel® Treatment Enbrel® initiate patient active infection include chronic localized infection Patients sepsis risk sepsis treat</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>